VRCC To Participate In Clinical Trial Evaluating The Efficacy Of A New Drug To Treat Dogs With Inoperable Grade 2 & 3 Mast Cell Tumours

VRCC is participating in a ‘Clinical Trial’ evaluating the efficacy of a New Drug to treat Dogs with inoperable Grade 2 & 3 Mast Cell Tumours VRCC offers all the most modern treatments for Dogs with Mast Cell Tumours but this ‘Trial’ treatment is now available at VRCC for Dogs where current treatment may not be appropriate or where clients do not or are unable to pursue the conventional route. For full details contact: Beatriz Balana Tapia or Dr Susan North at: VRCC Veterinary Referrals No1 Bramston Way Southfields. Laindon. Essex. SS15 6TP Te: 01268 564664

More from

• VDS launches VetResolve to help practices meet new complaints handling requirements
• Ronda.vet links locum shifts to CPD rewards in UK veterinary first
• Cancellations have been damaging locum work for years but no-one was keeping count - now Ronda is
• Vet-founded charity looking to support talented youngsters
• Virbac Confirms Immediate UK Availability of Syvazul BTV 8 Vaccine for Livestock Protection